Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Cackett

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMC Ophthalmology|January 31, 2018
Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumabFlora Elwes, Shyamanga Borooah, Peter Aspinall, et al.
American Journal of Ophthalmology|August 30, 2008
Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye StudyPeter Cackett, Tien Y Wong, Tin Aung, et al.
Ophthalmology|December 15, 2010
Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese personsPeter Cackett, Ian Yeo, Chui Ming Gemmy Cheung, et al.
Eye (London, England)|October 7, 2022
Practical implementation of a q4-q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panelClare Bailey, Peter Cackett, Ajay Kotagiri, et al.
Eye (London, England)|January 16, 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelRichard Gale, Mahmoud Husseiny Awad, Clare Bailey, et al.
Investigative Ophthalmology & Visual Science|August 30, 2012
Association of genetic variants on 8p21 and 4q12 with age-related macular degeneration in Asian populationsIsao Nakata, Kenji Yamashiro, Yumiko Akagi-Kurashige, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMC Ophthalmology|January 31, 2018
Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumabFlora Elwes, Shyamanga Borooah, Peter Aspinall, et al.
American Journal of Ophthalmology|August 30, 2008
Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye StudyPeter Cackett, Tien Y Wong, Tin Aung, et al.
Ophthalmology|December 15, 2010
Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese personsPeter Cackett, Ian Yeo, Chui Ming Gemmy Cheung, et al.
Eye (London, England)|October 7, 2022
Practical implementation of a q4-q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panelClare Bailey, Peter Cackett, Ajay Kotagiri, et al.
Eye (London, England)|January 16, 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelRichard Gale, Mahmoud Husseiny Awad, Clare Bailey, et al.
Investigative Ophthalmology & Visual Science|August 30, 2012
Association of genetic variants on 8p21 and 4q12 with age-related macular degeneration in Asian populationsIsao Nakata, Kenji Yamashiro, Yumiko Akagi-Kurashige, et al.
Pageof 2